Announcement on Announcement on Change of Sponsor Representative for Continuous Supervision
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Change of Sponsor Representative for Continuous Supervision
Filed with SSE · · 2 pages · Chinese
On 6ix: 6ix.com/news/announcement-on-change-of-sponsor-representative-for-continuous-supervision-122
Release
Earlier from InnoCare Pharma
- Announcement on Listing and Circulation of Initial Public Offering of Strategic Placement Restricted Shares
- Announcement on Voluntary Disclosure of Clinical Trial Progress of Aobrutinib
- Semi-annual Report in 2024
- Announcement on Convening the 2024 Semi-Annual Performance Briefing
- Announcement on Voluntary Disclosure of Completing the 1st Administration of ICP-332 in Patients in the United States
Later from InnoCare Pharma
- Announcement on the Resignation of Non-executive Directors and Independent Non-executive Directors and the Change of Members of Special Committees of the Board of Directors
- Announcement on Voluntary Disclosure of Phase II Clinical Trial Result of ICP-488
- Announcement on Convening the Q3 2024 Performance Briefing
- The Q3 2024 Report
- Summary Announcement on the 2024 STAR Market Restricted Stock Incentive Plan (Draft)
Follow InnoCare Pharma into a list and get an email when it puts out news.
Follow InnoCare Pharma